Fabrazyme and renal failure chronic 
Fabrazyme and renal failure chronic Patient Reports February 11, 2012
Fabrazyme Side Effects Report #4685112-X
Fabrazyme side effect was reported by a Pharmacist from on Feb 14, 2005. Male patient, 71 years of age, weighting 142.6 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: haemodialysis-induced symptom, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with PRAVACHOL, FLOVENT, LASIX, AMLODIPINE, ASPIRIN, PLAVIX, PHOSLO, ROCALTROL. Patient recovered.
Fabrazyme Side Effects Report #5386006-7
Fabrazyme side effect was reported by a Physician from GERMANY on June 26, 2007. Male patient, 58 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, coronary artery bypass
, haemodialysis, hip arthroplasty, renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient died on 01/01/2007.Fabrazyme Side Effects Report #5410354-5
Fabrazyme side effect was reported by a Physician from GERMANY on July 30, 2007. Male patient, 58 years of age, weighting 138.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arrhythmia
, coronary artery disease , osteonecrosis , renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient died on 06/01/2007.Fabrazyme Side Effects Report #4868471-4
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 13, 2005. Male patient, 58 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: abdominal pain
, azotaemia, cardiopulmonary failure, cerebrovascular accident, encephalopathy, myocardial infarction, renal failure chronic, treatment noncompliance. Fabrazyme dosage: 55 MG ONCE IV. During the same period patient was treated with TOPROL, NORVASC, ALBUTEROL, PHOSLO, SPIRIVA, EPOGEN. Patient was hospitalized. Patient died on 12/05/2005.Fabrazyme Side Effects Report #5748503-1
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on May 07, 2008. Male patient, 57 years of age, weighting 159.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: dialysis
, renal failure chronic, renal transplant. Fabrazyme dosage: 75 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5818894-1
Fabrazyme side effect was reported by a Physician from UNITED STATES on July 14, 2008. Male patient, 57 years of age, weighting 159.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 75 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5326876-1
Fabrazyme side effect was reported by a Physician from JAPAN on Apr 27, 2007. Male patient, 55 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: altered state of consciousness, cardiac failure chronic, haemodialysis, hypotension, renal failure chronic, sick sinus syndrome. Fabrazyme dosage: 45 MG Q2WKS IV. Patient was hospitalized. Patient died on 04/17/2007.
Fabrazyme Side Effects Report #5757566-9
Fabrazyme side effect was reported by a Physician from JAPAN on May 15, 2008. Male patient, 54 years of age, weighting 152.1 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cardiac failure chronic, cerebral haemorrhage, condition aggravated, dialysis
, mitral valve incompetence, pericardial effusion, renal failure chronic, tricuspid valve incompetence. Fabrazyme dosage: 65 MG, Q2W, INTRAVENOUS; 70 MG Q2W, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, CARVEDILOL, TRICHLORMETHIAZIDE, PIMOBENDAN, BENIDIPINE HYDROCHLORIDE, ALLOPURINOL, PRAVASTATIN. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4761250-8
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 13, 2005. Male patient, 54 years of age, weighting 157.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #4761027-3
Fabrazyme side effect was reported by a Physician from UNITED STATES on Aug 23, 2005. Male patient, 54 years of age, weighting 166.9 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arteriovenous graft, haemodialysis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #4762700-3
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on June 13, 2005. Male patient, 54 years of age, weighting 157.2 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5093632-1
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Male patient, 53 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with MAGNESIUM OXIDE, PEPCID, VITE, SYNTHROID, POTASSIUM CHLORIDE, LACTINEX, NEUTRA. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5108055-6
Fabrazyme side effect was reported by a Physician from UNITED STATES on Sept 07, 2006. Male patient, 53 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with MAGNESIUM OXIDE, PEPCID, VITE, SYNTHROID, POTASSIUM CHLORIDE, LACTINEX, NEUTRA. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5679146-6
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2008. Male patient, 53 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic. Fabrazyme dosage: 55 MG, Q2W, INTRAVENOUS. Patient died on 03/11/2008.
Fabrazyme Side Effects Report #4890753-0
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Jan 10, 2006. Male patient, 49 years of age, weighting 134.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cerebrovascular accident, haemodialysis, hypertension, renal failure chronic. Fabrazyme dosage: 35 MG QWK IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4761330-7
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on July 19, 2005. Female patient, 48 years of age, weighting 276.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: alopecia, catheterisation venous, muscle twitching, renal failure chronic. Fabrazyme dosage: 125 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #4565629-9
Fabrazyme side effect was reported by a Health Professional from on Jan 14, 2005. Male patient, 47 years of age, weighting 131.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4829989-3
Fabrazyme side effect was reported by a Physician from JAPAN on Nov 02, 2005. Male patient, 46 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, fabry's disease, haemodialysis, renal failure chronic. Fabrazyme dosage: 55 MG Q2WKS IV. During the same period patient was treated with ACE INHIBITOR, ANGIOTENSIN RECEPTOR BLOCKER. Patient recovered.
Fabrazyme Side Effects Report #4551470-X
Fabrazyme side effect was reported by a Consumer or non-health professional from on Dec 28, 2004. Male patient, 45 years of age, weighting 145.7 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: loss of consciousness, myocardial infarction, peritoneal dialysis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with NORVASC, TOPROL, ALBUTEROL, PAXIL, ADVAIR DISKUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5199836-1
Fabrazyme side effect was reported by a Physician from FRANCE on Dec 18, 2006. Male patient, 44 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #6005060-2
Fabrazyme side effect was reported by a Physician from UNITED STATES on Dec 02, 2008. Male patient, 44 years of age, weighting 143.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: cerebrovascular accident, infusion related reaction, nausea
, renal failure chronic, renal transplant. Fabrazyme dosage: 65 MG, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, ASPIRIN, CALCITRIOL, CALCIUM CARBONATE, CLOTRIMAZOLE, DOCUSATE, METOPROLOL TARTRATE, MYCOPHENOLIC ACID. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #4746176-8
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2005. Male patient, 44 years of age, weighting 209.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic, renal transplant. Fabrazyme dosage: 90 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4748477-6
Fabrazyme side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2005. Male patient, 44 years of age, weighting 209.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, renal failure chronic. Fabrazyme dosage: 88 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4828068-9
Fabrazyme side effect was reported by a Physician from ESTONIA on Nov 02, 2005. Male patient, 40 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: complications of transplanted kidney, haemodialysis, renal artery thrombosis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4831947-X
Fabrazyme side effect was reported by a Physician from ESTONIA on Nov 08, 2005. Male patient, 40 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: arterial thrombosis, complications of transplanted kidney, haemodialysis, renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, CALCI, NEORECORMON. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4846755-3
Fabrazyme side effect was reported by a Physician from ESTONIA on Nov 23, 2005. Male patient, 40 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: complications of transplanted kidney, haemodialysis, renal artery thrombosis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. During the same period patient was treated with ENALAPRIL, CALCI, NEORECORMON. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4579379-6
Fabrazyme side effect was reported by a Physician from on Jan 31, 2005. Male patient, 38 years of age, weighting 143.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: deafness unilateral, renal failure chronic, renal transplant. Fabrazyme dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with CELLCEPT, PROGRAF, VALCYTE, BACTRIM, NYSTATIN, ZANTAC, SENOKOT. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4876255-6
Fabrazyme side effect was reported by a Pharmacist from UNITED STATES on Dec 22, 2005. Male patient, 38 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5279893-4
Fabrazyme side effect was reported by a Physician from JAPAN on Mar 12, 2007. Male patient, 37 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, peritoneal dialysis, renal failure chronic, renal transplant, renal vein thrombosis, transplant failure. Fabrazyme dosage: 60 MG Q2WKS IV. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5166797-0
Fabrazyme side effect was reported by a Physician from ARGENTINA on Nov 16, 2006. Male patient, 37 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: deafness neurosensory, dialysis
, dizziness , hypertension, ill-defined disorder, renal failure chronic, treatment noncompliance. Fabrazyme dosage: unknown. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #5142736-3
Fabrazyme side effect was reported by a Physician from JAPAN on Oct 13, 2006. Male patient, 36 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: biopsy kidney abnormal, haemodialysis, renal failure chronic, renal transplant. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5153673-2
Fabrazyme side effect was reported by a Physician from JAPAN on Oct 30, 2006. Male patient, 36 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: bk virus infection, haemodialysis, renal failure chronic, renal transplant, urine analysis abnormal. Fabrazyme dosage: 55 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5708774-4
Fabrazyme side effect was reported by a Physician from ARGENTINA on Apr 08, 2008. Male patient, 36 years of age, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: deafness neurosensory, dialysis
, dizziness , fibrosis, hypertension, renal failure chronic, treatment noncompliance, viiith nerve lesion. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.Fabrazyme Side Effects Report #6012633-X
Fabrazyme side effect was reported by a Physician from JAPAN on Dec 03, 2008. Male patient, 36 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: haemodialysis, renal failure chronic, renal transplant. Fabrazyme dosage: 55 MG, Q2W, INTRAVENOUS. During the same period patient was treated with CILNIDIPINE, TELMISARTAN, SPHERICAL ABSORBENT COAL, HYDROXYZINE, CARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5009153-8
Fabrazyme side effect was reported by a Physician from UNITED STATES on May 08, 2006. Male patient, 34 years of age, weighting 165.3 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: kidney transplant rejection, peritoneal dialysis, renal failure chronic. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #6127313-X
Fabrazyme side effect was reported by a Physician from UNITED STATES on Mar 11, 2009. Male patient, 33 years of age, weighting 136.0 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5199475-2
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2006. Male patient, 29 years of age, weighting 156.5 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #4579378-4
Fabrazyme side effect was reported by a Physician from on Jan 27, 2005. Female patient, 22 years of age, weighting 101.4 lb, was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: renal failure chronic, renal transplant. Fabrazyme dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5913677-6
Fabrazyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 23, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, renal failure chronic, renal transplant. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5955953-7
Fabrazyme side effect was reported by a Physician from UNITED STATES on Oct 29, 2008. Male patient was diagnosed with fabry's disease and was treated with Fabrazyme. After drug was administered, patient experienced the following side effects: chills, haemodialysis, infusion related reaction, renal failure chronic, renal transplant. Fabrazyme dosage: 1 MG/KG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, BENADRYL. Patient was hospitalized. Patient recovered.